NasdaqGS:AMGNBiotechs
Amgen (AMGN) Stock Valuation Looks Split Between Analyst Targets And DCF Upside
Event context and recent performance
Amgen (AMGN) has been in focus after recent trading, with the stock last closing at US$355.20. Over the past month it gained about 5.6%, while the past 3 months show a decline of roughly 3.0%.
See our latest analysis for Amgen.
That recent 5.6% 1 month share price return sits against an 8.4% year to date share price gain, while the 1 year total shareholder return of 23.9% points to momentum that has been building over a longer stretch.
If Amgen has you...